Medical devices

One year experience on EU Medical Devices Regulation (MDR) 2017/745 for single integral drug-device combination products

By Giovanni Campana2022-06-23T10:39:00

AdobeStock_278890190

Source: Adobe Stock

 Since 26 May 2021, Article 117 of the MDR asks for a notified body opinion (NBOp) to be included in the marketing authorisation applications (MAAs) for medicinal products that are a single integral drug-device combination…

 

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

Not a TOPRA member yet? 

Join now to get access to:

  • Features and specialist articles
  • CPD supplements
  • Comprehensive archive

Become a member today!

Not sure yet?  Read one of our free editorials to see what you’re missing out on!